Ozempic research is ‘exciting’, says British Heart Foundation’s Chief Medical Officer

United Kingdom News News

Ozempic research is ‘exciting’, says British Heart Foundation’s Chief Medical Officer
United Kingdom Latest News,United Kingdom Headlines
  • 📰 Channel4News
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 68%

We spoke to Professor Bryan Williams, the Chief Scientific and Medical Officer at the British Heart Foundation.

We spoke to Professor Bryan Williams, the Chief Scientific and Medical Officer at the British Heart Foundation, who’s attending the conference in London, and began by asking for his assessment of claims that it could slow ageing and prolong life.So my assessment of that is if you are overweight, and particularly if you’re extremely overweight and you develop type two diabetes as well, then we already know that shortens life.

I suspect if people were able to reduce their weight by an equivalent amount, by following longstanding guidance to eat healthy and take more exercise and ‘look after yourself’, we’d probably get the same benefits. And that’s probably one of the reasons why people who adopt those lifestyles don’t get those diseases that we’ve just mentioned quite so often until very late in their longer lives.And just in terms of the whole picture, this drug won’t necessarily suit everyone.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Channel4News /  🏆 27. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Heart transplant list doesn't rank kids by medical need, study findsHeart transplant list doesn't rank kids by medical need, study findsThe method used across the United States to wait-list children for heart transplants does not consistently rank the sickest patients first, according to a new study led by Stanford Medicine experts.
Read more »

Wearable heart monitor enhances diagnosis of irregular heart rhythm, study findsWearable heart monitor enhances diagnosis of irregular heart rhythm, study findsWearable, long-term continuous heart monitors helped identify 52% more cases of atrial fibrillation compared to usual care, but that did not lead to a reduction in hospitalizations due to stroke, according to a study led by the Duke Clinical Research Institute.
Read more »

Corrie star shares 'unusual' part of Beth's exit with co-star 'heart-to-heart'Corrie star shares 'unusual' part of Beth's exit with co-star 'heart-to-heart'It was just days ago Lisa confirmed she was leaving the ITV soap 13 years after joining as Beth Tinker
Read more »

Self-assembling heart stimulator can correct heart arrhythmia in emergency situationsSelf-assembling heart stimulator can correct heart arrhythmia in emergency situationsBy injecting a solution of nanoparticles around the heart, a temporary heart stimulator self-assembles, which can correct heart arrhythmia in emergency situations with the help of an external power source.
Read more »

Research team discovers how Copaxone protects the heart muscle and improves its function after heart attackResearch team discovers how Copaxone protects the heart muscle and improves its function after heart attackIn the late 1960s, three Weizmann Institute of Science researchers developed several protein-like molecules, called copolymers, that they believed would produce a disease similar to multiple sclerosis in laboratory animals. The scientists—Prof. Michael Sela, Prof. Ruth Arnon and Dr.
Read more »

Weight loss drug's heart benefits extend to people with heart failure, study findsWeight loss drug's heart benefits extend to people with heart failure, study findsThe anti-obesity medication semaglutide may help to prevent heart attacks and other major adverse cardiac events among overweight people who have cardiovascular disease, whether or not they also have heart failure, according to a new study led by UCL's Professor John Deanfield.
Read more »



Render Time: 2025-02-14 21:36:11